Live Breaking News & Updates on Information Reporting Requirements

Stay updated with breaking news from Information reporting requirements. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

FinCEN's Proposed Rule Would Broadly Expand Beneficial Ownership Reporting Requirements - Corporate/Commercial Law

On December 8, the Financial Crimes Enforcement Network ("FinCEN"), within the U.S. Department of the Treasury, published proposed regulations, Beneficial Ownership Information Reporting Requirements (the "Proposed Rule"). ....

United States , Company Applicants , Us Department Of The Treasury , Investment Company , Exchange Commission , Domestic Reporting Companies , Foreign Reporting Companies , Financial Crimes Enforcement Network , Beneficial Ownership , Information Reporting Requirements , Corporate Transparency Act , Anti Money Laundering Act , Customer Due Diligence , Proposed Rule , Reporting Companies , Identification Number , Bradstreet Data Universal Numbering System , Legal Entity Identifier , Secure System , Investment Company Act , Fincens Proposed Rule Would Broadly Expand Beneficial Ownership Reporting Requirements , Corporate Commercial Law , Corporate And Company Law , Venture Capital , Public Sector , Money Laundering ,

2020 Highlights in Canadian Life Sciences IP and Regulatory Law | Smart & Biggar

1. COVID-19: CIPO, Federal Courts, Health Canada
In response to the pandemic, we saw quick action and flexibility from:
the
Canadian Intellectual Property Office (CIPO) – deadlines from March 16 to August 28 were extended until August 31. On December 14, the Trademarks Office began accepting requests for expedited examination of trademark applications associated with medical goods or services related to COVID-19;
the
Federal Courts – Federal Court (FC) deadlines were suspended until June 29 or July 13, depending on the province, and a number of hearings and patent trials were conducted by Zoom. Federal Court of Appeal (FCA) deadlines continue to be suspended for some appeals, but are being lifted for selected files on a weekly basis. The FC held that the 45-day time limit for commencing a s. 6(1) action under the ....

Astrazenecav Sandoz , Urszula Wojtyra , Eli Lillyv Teva , Infresenius Kabi , Katie Lee , Fresenius Kabi , Eli Lillyv Mylan , Janssenv Teva , Hospirav Kennedy , Pharmasciencev Bayer , Eli Lillyv Apotex , Allerganv Sandoz , Eli Lillyv Pharmascience , Apotexv Allergan , Eli Lilly , Trademarks Office , Quebec Superior Court On , House Of Commons Standing Committee On Health , Canadian Intellectual Property Office , Health Canada , Federal Courts , Amended Regulations , Federal Court , Patented Medicines , Time Limits , Interim Order ,

Amendments to PMPRB Regulations will now be in force July 1, 2021 | Smart & Biggar

July 1, 2021. The amendments delaying the coming-into-force date (see here) will be published in the Canada Gazette II on January 20, 2021. Accordingly, the reporting requirements due by January 31, 2021 of sales and pricing information for the period from July 1, 2020 to December 31, 2020 will be governed by the current Regulations.
These new regulations - officially titled
Regulations amending the Regulations Amending the Patented Medicines Regulations (Additional Factors and Information Reporting Requirements), No. 2 - push back the timelines for reporting a cost-utility analysis prepared by a publicly funded Canadian organization under new section 4.1(4) and estimated maximum use of the medicine under new section 4.2(4) by
six months. Similarly, section 4.4 will require the Board to consider excessive pricing based on the three new pharmacoeconomic factors for sales in Canada after ....

Quebec Superior Court , Patented Medicine Prices Review Board Regulations , Regulations Amending , Patented Medicines Regulations , Additional Factors , Information Reporting Requirements , Canada Gazette , Amending Regulations , Federal Court , க்வீபெக் உயர்ந்தது நீதிமன்றம் , காப்புரிமை பெற்றது மருந்து ப்ரைஸஸ் விமர்சனம் பலகை ஒழுங்குமுறைகள் , காப்புரிமை பெற்றது மருந்துகள் ஒழுங்குமுறைகள் , தகவல் புகாரளித்தல் தேவைகள் , கனடா கஸெட் , கூட்டாட்சியின் நீதிமன்றம் ,